Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Artelo Biosciences, Inc. (ARTL) had Tangible Shareholders Equity of $-3.44M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.22M |
|
-- |
|
-- |
|
$3.15M |
|
$-3.15M |
|
$-0.07M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.15M |
|
$-3.15M |
|
0.57M |
|
0.57M |
|
$-5.61 |
|
$-5.61 |
|
| Balance Sheet Financials | |
$2.23M |
|
-- |
|
$2.12M |
|
$4.36M |
|
$5.71M |
|
-- |
|
$0.05M |
|
$5.76M |
|
$-1.41M |
|
|
Tangible Shareholders Equity |
$-3.44M |
$-1.41M |
|
0.70M |
|
| Cash Flow Statement Financials | |
$-2.11M |
|
-- |
|
$1.82M |
|
$2.34M |
|
$2.07M |
|
$-0.27M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.39 |
|
-- |
|
-- |
|
-- |
|
-0.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
229.09% |
|
93.50% |
|
-73.93% |
|
229.09% |
|
$-2.00 |
|
$-3.68 |
|
$-3.68 |
|